First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatin

R Iacovelli, C Ciccarese, M Brunelli, N Battelli, C Buttigliero, C Caserta, S Buti, D Santini, C Carella, L Galli, E Verri, P Ermacora, S Merler, C Masini, R De Vivo, L Milesi, F Spina, M Rizzo, I Sperduti, G Fornarini, G Tortora

Annals of Oncology, Nov. 22

Abstract link

© 2022 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.